The Prevention of Medication-related Osteonecrosis of the Jaw.

about

The Prevention of Medication-related Osteonecrosis of the Jaw.

Item

http://www.wikidata.org/entity/Q36292333

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

The Prevention of Medication-related Osteonecrosis of the Jaw.

@ast

The Prevention of Medication-related Osteonecrosis of the Jaw.

@en

type

Item

label

The Prevention of Medication-related Osteonecrosis of the Jaw.

@ast

The Prevention of Medication-related Osteonecrosis of the Jaw.

@en

prefLabel

The Prevention of Medication-related Osteonecrosis of the Jaw.

@ast

The Prevention of Medication-related Osteonecrosis of the Jaw.

@en

P1476

The Prevention of Medication-related Osteonecrosis of the Jaw.

@en

P2093

Monika Engelhardt

http://www.w3.org/2001/XMLSchema#string

Pit Voss

http://www.w3.org/2001/XMLSchema#string

P2860

Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised, crossover study of community vs hospital bisphosphonate administration

Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project

Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates.

American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma.

Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients

Bisphosphonates for osteoporosis--where do we go from here?

Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both?

Incidence and mortality of hip fractures in the United States

Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw.

Discovery, clinical development, and therapeutic uses of bisphosphonates.

P304

63-69

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3238/ARZTEBL.2017.0063

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

114

http://www.w3.org/2001/XMLSchema#string

P50

Rainer Schmelzeisen

Philipp Poxleitner

P577

2017-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28241916

http://www.w3.org/2001/XMLSchema#string

P932

5331477

http://www.w3.org/2001/XMLSchema#string